Network to strengthen the participation in chronicall ilness using the example of multiple sclerosis

Network to strengthen the participation in chronicall ilness using the example of multiple sclerosis - MSnetWork

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00025451

Enrollment

950

Registered

2022-07-08

Start date

2022-03-02

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G35

Interventions

Group 1: In cases of sick leave, work problems or problems with participation randomized multiprofessional intervention with coordinated care (social medicine, occupational medicine, rehabilitation me

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Confirmed diagnosis of multiple sclerosis (ICD-10: G35.XX G), academic studies, professional training or work. Place of residence in Bavaria, Berlin, Brandenburg or Mecklenburg-Western Pomerania.

Exclusion criteria

Exclusion criteria: Inability to work, higher care level, severe mental disorders (ICD-10: F10.7, F20-29, F32.2-3; F33.2-3), cognitive disorder (ICD F00-F09)

Design outcomes

Primary

Measure	Time frame
The primary endpoint is the number of days of sick leave due to MS. The number of days of sick leave or incapacity for work due to MS per patient year is determined on the basis of the secondary data of the health insurance companies of the included patients. A comparison is made between the control group and the intervention group after 12 months. In addition, the days of incapacity for work are queried via a semi-annual patient questionnaire and documented during the quarterly or semi-annual examinations by the treating neurologist.	—

Measure

Time frame

The primary endpoint is the number of days of sick leave due to MS. The number of days of sick leave or incapacity for work due to MS per patient year is determined on the basis of the secondary data of the health insurance companies of the included patients. A comparison is made between the control group and the intervention group after 12 months. In addition, the days of incapacity for work are queried via a semi-annual patient questionnaire and documented during the quarterly or semi-annual examinations by the treating neurologist.

—

Secondary

Measure	Time frame
The following secondary endpoints are considered in the evaluation study in MSnetWork: (1) Costs of incapacity for work (continuous evaluation of the secondary data of the participating health insurance companies, if necessary information from the patient survey after 0, 6, 12, 18, 24 months) (2) Treatment costs and frequency (continuous evaluation of the secondary data of the participating health insurance companies, if necessary information from the patient survey after 0, 6, 12, 18, 24 months) (3) (Household) costs for the patient, e.g. for co-payments and distances (patient survey after 0, 6, 12, 18, 24 months) (4) Implementation potential in routine care (acceptance survey of the med. personnel and determination of intervention costs via time labelling/survey of MSnetWork participants, continuously from study month 12) (5) Acquisition prognosis (by means of SPE and patient survey, patient questionnaire after 0, 12, 24 months) (6) Functional capacity (using EDSS, MSFC walking distance and MSFC-9HPT, assessment in neurological practice after 0, 6, 12, 18, 24 months) (7) Cognitive, affective status and fatigue (by means of SDMT - assessment in neurological practice after 0, 6, 12, 18, 24 months; by means of DASS and FSMC, patient questionnaire after 0, 6, 12, 18, 24 months) (8) Health-related quality of life (using MSQoL-54 and EQ-5D-5L, patient questionnaire after 0, 6, 12, 18, 24 months) (9) Therapy adherence (using AAQ, patient questionnaire after 0, 6, 12, 18, 24 months) (10) Self-efficacy (using CSES, patient questionnaire after 0, 6, 12, 18, 24 months) (11) Patient satisfaction (using ZUF-8, patient questionnaire at 12 and 24 months).	—

Measure

Time frame

The following secondary endpoints are considered in the evaluation study in MSnetWork: (1) Costs of incapacity for work (continuous evaluation of the secondary data of the participating health insurance companies, if necessary information from the patient survey after 0, 6, 12, 18, 24 months) (2) Treatment costs and frequency (continuous evaluation of the secondary data of the participating health insurance companies, if necessary information from the patient survey after 0, 6, 12, 18, 24 months) (3) (Household) costs for the patient, e.g. for co-payments and distances (patient survey after 0, 6, 12, 18, 24 months) (4) Implementation potential in routine care (acceptance survey of the med. personnel and determination of intervention costs via time labelling/survey of MSnetWork participants, continuously from study month 12) (5) Acquisition prognosis (by means of SPE and patient survey, patient questionnaire after 0, 12, 24 months) (6) Functional capacity (using EDSS, MSFC walking distance and MSFC-9HPT, assessment in neurological practice after 0, 6, 12, 18, 24 months) (7) Cognitive, affective status and fatigue (by means of SDMT - assessment in neurological practice after 0, 6, 12, 18, 24 months; by means of DASS and FSMC, patient questionnaire after 0, 6, 12, 18, 24 months) (8) Health-related quality of life (using MSQoL-54 and EQ-5D-5L, patient questionnaire after 0, 6, 12, 18, 24 months) (9) Therapy adherence (using AAQ, patient questionnaire after 0, 6, 12, 18, 24 months) (10) Self-efficacy (using CSES, patient questionnaire after 0, 6, 12, 18, 24 months) (11) Patient satisfaction (using ZUF-8, patient questionnaire at 12 and 24 months).

—

Countries

Germany

Contacts

Public ContactBarbara Prodanovic

Berufsverband Deutscher Neurologen e.V.

kontakt@msnetwork.info030 94878312

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 10, 2026